Poliomyelitis Completed Phase 1 Trials for Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796)

Back to Poliomyelitis

Also known as: Polio / Acute poliomyelitis, unspecified / Acute unspecified poliomyelitis / Polio acute / Acute poliomyelitis / Poliomyelitis NOS / Acute poliomyelitis (disorder) / Epidemic acute poliomyelitis (disorder) / Heine-Medin disease / Poliomyelitis (acute) / Poliomyelitis acute

Indication	Status	Phase
DBCOND0013769 (Poliomyelitis)	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01997632	Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults	Prevention	Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795) Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796) Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797)